Evaluation of serum adenosine deaminase levels with components of metabolic syndrome

Journal Title: International Journal of Clinical Biochemistry and Research - Year 2016, Vol 3, Issue 3

Abstract

Introduction: Metabolic syndrome is a major worldwide health problem leading to markedly increased mortality and serious morbidity. The major features of the metabolic syndrome include central obesity, hypertriglyceridemia, low high-density lipoprotein (HDL) cholesterol, hyperglycemia, and hypertension. Adenosine, regulates adipokines secretion by adipose tissue. They will regulate free fatty acid oxidation and it has the capacity to act like insulin on adipose tissue. Increased Adenosine Deaminase(ADA) activity leads to decrease in adenosine in adipose tissue. Since a relationship exists between adenosine deaminase and metabolic syndrome, we have undertaken a preliminary study to determine its plasma activity in metabolic syndrome cases and highlight its importance by comparing its activity with each component of metabolic syndrome. Objectives: To estimate serum ADA, Fasting blood sugar (FBS), Triglyceride (TG), HDL, Waist circumference (WC) & Blood pressure (BP) in cases and controls and to correlate serum ADA with FBS, TG, HDL, WC & BP in cases of Metabolic syndrome. Materials & Methods: The study was conducted on 50 diagnosed cases of Metabolic syndrome and 50 age and sex matched healthy subjects. ADA estimated by Guisti and Gulanti method, FBS by GOD - POD method, HDL-C by Immunoinhibition method, TG by GPO-PAP method, Waist circumference & BP measured as per WHO criteria. Statistical analysis was done using SPSS-17. Results: Serum ADA, FBS & TG levels, waist circumference, Blood Pressure levels were significantly elevated in cases compared to controls. Serum HDL levels was significantly decreased in cases compared to controls. Correlation was positive and significant when ADA activity was compared with FBS, TG, WC & BP and correlation was negative and significant when ADA activity was compared with HDL in cases. Conclusion: These findings clearly project an early detection of elevation of ADA levels may help in early prevention and management of metabolic syndrome and its complications.

Authors and Affiliations

Netravathi Basappa Sajjan, Asmabi Makandar

Keywords

Related Articles

To study an alteration in biochemical parameters in acute and chronic phase of respiratory acidosis and alkalosis

Introduction: The primary abnormality in respiratory acidosis is retention of CO2 (increased H2CO3) due to impaired alveolar ventilation resulting in a rise in pCO2 causing acidemia. However, respiratory alkalosis occurs...

Prevalence of Haemoglobinopathies in Punjabi population

Background: The prevalence of thalassemias and various hemoglobinopathies are a major public health problem in Punjabi population. These cases are mainly overlooked and thus only treated as a part of anaemia. Thus it is...

Oxidative stress and antioxidant status in coronary artery disease patients before percutaneous transluminal coronary angioplasty

Introduction: Oxidant lead to cell death through apoptosis and necrosis. The effects of reactive oxygen radicals are balanced by the antioxidant action. The aim of the study was to assess oxidative stress and antioxidant...

Serum osteocalcin: A potential biomarker for primary osteoporosis

Osteoporosis is a silent killer usually asymptomatic and noticed only after a fracture Women irrespective of their origin and social strata show an accelerated phase of bone loss for about 10 yrs after the cessation of o...

Circulating thyroid hormones with serum uric acid and creatinine in hypo and hyperthyroidism

Introduction: Thyroid dysfunction is related to damaging effect on glomerular and tubular functions. In recent studies it was found that hypo and hyperthyroidism was accompanied with renal derangement resulting in abnorm...

Download PDF file
  • EP ID EP242747
  • DOI -
  • Views 85
  • Downloads 0

How To Cite

Netravathi Basappa Sajjan, Asmabi Makandar (2016). Evaluation of serum adenosine deaminase levels with components of metabolic syndrome. International Journal of Clinical Biochemistry and Research, 3(3), 285-291. https://europub.co.uk/articles/-A-242747